The reduction in tumor load was confirmed by the measurements of mRNA levels of alpha-fetoprotein (AFP), a HCC biomarker, which was significantly reduced in SphK1−/− compared to WT mice (Figure 2E). The gene discussed is SPHK1; the disease is neoplasm.